***Registration for this event is now closed, for enquiries into registration please email laurabacchus@onenucleus.com***

Rapid advances in both technology and knowledge have opened up new possibilities for treating disease. Cell and gene therapies now have the potential to ‘treat the untreatable’, bringing hope to millions of people worldwide. Innovative vaccines and vaccine strategies have also brought the ability to prevent or control disease outbreaks in new ways. 

In this rapidly changing landscape, how are the treatments being developed, and what might be the barriers to success?
The panel at this event will discuss:

•    Cell and Gene therapy: where are we now, and where can we get to?
•    What are the risks?
•    How to break down the barriers?
•    Collaboration: help or hindrance?

Agenda:
18.00 - Registration & networking

18.30 - Welcome from the host – Rich Ferrie, London BioScience Innovation Centre
  
18.40 - Introduction from the chair - Tony Jones, CEO, One Nucleus

18.45 – Pitch decks and Panel Discussion: Cell and Gene Therapy

• William Raimes, Head of Process Development, Ori Biotech
• Michael Kyriakides, Life Sciences Investor, Synconca 
• Dirk Werling, Director, Centre for Vaccinology and Regenerative Medicine, Royal Veterinary College 
• Bams Abila, Visiting Professor (Clinical Pharmacology; Biologics & ATMPs), Kings College London

19.30 - Closing remarks
19.35 - Networking over drinks and canapés
21.00 - Close

This event is free to attend and open to all.